UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

Expert review of vaccines, 2018-06, Vol.17 (6), p.461-477

2018

Link zum Volltext

Verfügbarkeit prüfen

Meningococcal serogroup B vaccines: Estimating breadth of coverage

Human vaccines & immunotherapeutics, 2017-02, Vol.13 (2), p.255-265

2017

Link zum Volltext

Verfügbarkeit prüfen

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

Infectious diseases and therapy, 2020-09, Vol.9 (3), p.641-656

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older

Vaccine, 2022-03, Vol.40 (12), p.1872-1878

2022

Link zum Volltext

Verfügbarkeit prüfen

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec

mSphere, 2018-12, Vol.3 (6)

2018

Link zum Volltext

Verfügbarkeit prüfen

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

The New England journal of medicine, 2017-12, Vol.377 (24), p.2349-2362

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

The New England journal of medicine, 2006-10, Vol.355 (14), p.1445-1455

2006

Link zum Volltext

Verfügbarkeit prüfen

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

Vaccine, 2019-03, Vol.37 (12), p.1710-1719

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

The Pediatric infectious disease journal, 2016-05, Vol.35 (5), p.548-554

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

Vaccine, 2003-06, Vol.21 (19), p.2461-2467

2003

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents

The Pediatric infectious disease journal, 2016-06, Vol.35 (6), p.673-682

2016

Link zum Volltext

Verfügbarkeit prüfen

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA

Journal of allergy and clinical immunology, 2004-06, Vol.113 (6), p.1144-1151

2004

Link zum Volltext

Verfügbarkeit prüfen

Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/ Bovine Reassortant Rotavirus Vaccine

The Journal of infectious diseases, 2004-06, Vol.189 (12), p.2290-2293

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers

Vaccine, 2016-02, Vol.34 (6), p.809-813

2016

Link zum Volltext

Verfügbarkeit prüfen

Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity

Journal of allergy and clinical immunology, 2000-07, Vol.106 (1), p.124-134

2000

Link zum Volltext

Verfügbarkeit prüfen

Local Induction of a Specific Th1 Immune Response by Allergen Linked Immunostimulatory DNA in the Nasal Explants of Ragweed- Allergic Subjects

Allergology International, 2009, Vol.58 (4), p.565-572

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

Vaccine, 2006-01, Vol.24 (1), p.20-26

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

The Journal of pediatrics, 2004-02, Vol.144 (2), p.184-190

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy

Journal of allergy and clinical immunology, 2001-08, Vol.108 (2), p.191-197

2001

Link zum Volltext

Verfügbarkeit prüfen

Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity

European journal of immunology, 2000-07, Vol.30 (7), p.1939-1947

2000

Link zum Volltext

Verfügbarkeit prüfen

The complete nucleic acid sequence of gene segment 3 of the IDIR strain of group B rotavirus

Nucleic acids research, 1989-12, Vol.17 (23), p.10113-10113

1989

Link zum Volltext

Verfügbarkeit prüfen

Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4

The Pediatric infectious disease journal, 2004-03, Vol.23 (3), p.206-211

2004

Link zum Volltext

Verfügbarkeit prüfen

Letter to the editor: Importance of serum bactericidal activity for estimating the breadth of protection for new meningococcal vaccines

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-04, Vol.21 (15)

2016

Link zum Volltext

Verfügbarkeit prüfen

Gene 5 of the IDIR Agent (Group B Rotavirus) Encodes a Protein Equivalent to NS34 of Group A Rotavirus

Virology (New York, N.Y.), 1993-09, Vol.196 (1), p.298-302

Eiden, Joseph J.

1993

Link zum Volltext

Verfügbarkeit prüfen

The Dynamics of Staphylococcus aureus carriage and Comparisons by Age in Two Studies of an Investigational S aureus 4-Antigen Vaccine (SA4Ag)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(91)
Bücher
(1)

Sprache

Englisch
(92)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Humans
(43)
Biological And Medical Sciences
(36)
Immunology
(31)
Animals
(30)
Infectious Diseases
(27)
Microbiology
(27)
Fundamental And Applied Biological Sciences. Psychology
(25)
Female
(23)
Male
(22)
Virology
(19)
Medical Sciences
(18)
Rotavirus - Genetics
(17)
Rotavirus
(16)
Vaccines
(14)
Adult
(12)
Molecular Sequence Data
(12)
Vaccination
(12)
Adolescent
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

Meningococcal serogroup B vaccines: Estimating breadth of coverage

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA

Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/ Bovine Reassortant Rotavirus Vaccine

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers

Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity

Local Induction of a Specific Th1 Immune Response by Allergen Linked Immunostimulatory DNA in the Nasal Explants of Ragweed- Allergic Subjects

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy

Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity

The complete nucleic acid sequence of gene segment 3 of the IDIR strain of group B rotavirus

Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4

Letter to the editor: Importance of serum bactericidal activity for estimating the breadth of protection for new meningococcal vaccines

Gene 5 of the IDIR Agent (Group B Rotavirus) Encodes a Protein Equivalent to NS34 of Group A Rotavirus

The Dynamics of Staphylococcus aureus carriage and Comparisons by Age in Two Studies of an Investigational S aureus 4-Antigen Vaccine (SA4Ag)

Suchergebnisse filtern